Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
International Journal of Neurology and Neurosurgery

Volume  9, Issue 2, Jul-Dec 2017, Pages 149-156
 

Original Article

Clinical Significance of AQP4 Antibody Detection in Chinese Patients with Neuromyelitis Optica (NMO) and High-Risk NMO: A Meta-Analysis

Nagam Varshithreddy*, Yin Zhou*, Gu Yanzheng**, Dong Wan-Li*, Fang Qi*, Xue Qun*,**

*Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou Jiangsu Province, 215006, P.R.China. **Clinical Immunology Key Lab of Jiangsu Province, First Affiliated Hospital of Soochow University, and Institute of Medical Biotechnology, Soochow University, Suzhou, Jiangsu, 215006, P.R. China.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijnns.0975.0223.9217.12

Abstract

Aim: To determine the prognostic value of AQP4 (aqua protein 4) antibody in the cohort of Chinese patients, and evaluate the diagnosis of AQP4 antibody detection inneuromyelitisoptica (NMO) and HRNMO (highrisk NMO), and explore the treatment. Methods: China national Knowledge Infrastructure, Wanfang Data, China Biology Medicine disc, Chinesescience and technology journal database, PubMed, Embase and the Cochrane Library weresearched up to November 2014 for randomized control trails of related key words. The quality ofstudies was assessed according to the inclusion and exclusion criteria as recommended by the Cochrane Handbook for Systematic Reviews. Metaanalysis was conducted using STATA V.12. Results: Total 13 trials of 11 studies having 472 and 362 cases in NMO and HRNMO groups were included and the numbers of AQP4 antibody positive were 350 and 168 casesrespectively. The metaanalysis showed: The total AQP4 antibody positive ratein NMO group was higher than HRNMO group (RR=0.66y95%Cl (0.53, 0.83); after stratification, inthe cell based assay group (RR = 0.636, 95%CI (0.461, 0.878), the AQP4IgG positive rate in NMOgroup was higher than HRNMO. In indirect immunofluorescence assay method group (RR =0.681, 95%CI (0.460, 1.009), there were no significant differences in AQP4 antibody positive rate between two groups. The Egger linear regression and sensitivity analysis of these studies suggested no evidence of publication bias. Conclusion: The AQP4 antibody positive rate in NMO group was higher than in HRNMO group of Chinese population; with a significant difference between the two groups.

Keywords: Demyelinating Disease; Neuromyelitisoptica; HighRisk NMO; Aquaporin4 Antibody; MetaAnalysis. 


Corresponding Author : Nagam Varshithreddy, Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou Jiangsu Province, 215006, P.R. China.